Gabexate mesilate (FOY) protects against ceruletide-induced acute pancreatitis in the rat

Pancreas

Volumn 2, Issue 2, 1987, Pages 181-186

  Wisner, James R ^a   Renner, Ian G ^a   Grendell, James H ^b   Niederau, Claus ^b   Ferrell, Linda D ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute pancreatitis; Ceruletide; Gabexate mesilate; Protection

Indexed keywords

CERULETIDE; CERULETIDE DIETHYLAMINE; GABEXATE MESILATE; PROTEINASE INHIBITOR;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RAT;

ACUTE DISEASE; AMYLASES; ANIMAL; CAERULEIN; DISEASE MODELS, ANIMAL; GABEXATE; GUANIDINES; INFUSIONS, INTRAVENOUS; MALE; PANCREATITIS; PROTEASE INHIBITORS; RATS; RATS, INBRED STRAINS; SUPPORT, U.S. GOV'T, P.H.S.; TRYPSINOGEN;

EID: 0023519601     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/00006676-198703000-00010     Document Type: Article

References (45)

1. Onstad GR, Bubrick MR Pathophysiology. In: Toledo-Pereya LH, ed. The pancreas: principles of medical and surgical practice. New York: John Wiley & Sons, 1985:97116.
2. Renner IG, Savage WT, Pantoja JL, Renner VJ. Death due to acute pancreatitis: a retrospective analysis of 405 autopsy cases. Dig Dis Sci 1985;30:1005-18.
3. Steer ML. Etiology and pathophysiology of acute pancreatitis. In: Go VLW, Gardner JD, Brooks FP, Lebenthal E, DiMagno EP, Scheele GA, eds. The exocrine pancreas: biology, pathobiology, and diseases. New York: Raven Press, 1986:465-74.
4. Thompson AG. Proteinase inhibitors in experimental and clinical pancreatitis. Ann NY Acad Sci 1968;146:540-7.
5. Scheele G. Biochemical concepts and markers in acute pancreatitis. In: Gyr K, Singer M, Sarles H, eds. Pancreatitis: concepts and classification. Amsterdam: Elsevier, 1984:119-25.
6. Steer ML, Meldolesi J, Figarella C. Pancreatitis: the role of lysosomes. Dig Dis Sci 1984;29:934-8.
7. Adler G, Kern HF, Scheele GA. Experimental models and concepts in acute pancreatitis. In: Go VLW, Gardner JD, Brooks FP, Lebenthal E, DiMagno EP, Scheele GA, eds. The exocrine pancreas: biology, pathobiology, and diseases. New York: Raven Press, 1986:407-21.
8. Fishbein R, Murphy GP, Wilder RJ. The pleuropulmonary manifestations of pancreatitis. Dis Chest 1962;41:392-7.
9. Kellum IM, DeMeester TR, Elkins RC, Zuidema GD. Respiratory insufficiency secondary to acute pancreatitis. Ann Surg 1972;175:657-61.
10. Ranson JHC, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Respiratory complications in acute pancreatitis. Ann Surg 1974;179:557-64.
11. Carey LC. Extra-abdominal manifestations of acute pancreatitis. Surgery 1979;86:337-42.
12. Krasman M, Nostrant TT, Wilson JAP. Acute pancreatitis: medical aspects. In: Toledo-Pereya LH, ed. The pancreas: principles of medical and surgical practice. New York: John Wiley & Sons, 1985:181-205.
13. Regan PT, Malegelada JR, Go VLW, Wolf AM, DiMagno EP. A prospective study of the anti-secretory effects of cimetidine and glucagon in human acute pancreatitis. Mayo Clin Proc 1981;56:499-503.
14. Cameron JL, Mehigan D, Zuidema GD. Evaluation of atropine in acute pancreatitis. Surg Gynecol Obstet 1979; 148:206-8.
15. Kronberg O, Bulow S, Joergensen PN. A randomized double-blind trial of glucagon treatment of first attack of severe acute pancreatitis without associated biliary disease. Am J Gastroenterol 1980;73:423-5.
16. Goebell H, Ammann R, Herfarth C, et al. A double-blind trial of synthetic salmon calcitonin in the treatment of acute pancreatitis. Scan J Gastroenterol 1979;14:881-9.
17. MRC Working Party on the treatment of acute pancreatitis: death from acute pancreatitis. Lancet 1977;2:632-5.
18. Imrie CW, Benjamin IS, Ferguson JC, et al. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg 1978;65:337-41.
19. Cox AG, Armitage P, Hogg R, et al. Morbidity of acute pancreatitis: the effect of aprotinin and glucagon. Gut 1980; 21:334-9.
20. Muramatu M, Fujii S. Inhibitory effects of ω-guanidino esters on trypsin, plasmin, plasma kallikrein and thrombin. Biochim Biophys Acta 1972;268:221-4.
21. Tamura Y, Hirado M, Okamura K, Minato Y, Fujii S. Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, C1ř and C1 esterase. Biochim Biophys Acta 1977;484:417-22.
22. Takasugi S, Toki N. Inhibitory effects of native and synthetic protease inhibitors on plasma proteases in acute pancreatitis. Hiroshima J Med Sci 1980;29:189-94.
23. Freise J, Magerstedt P, Schmid K. Inhibition of phospholipase A2 by gabexate mesilate, camostate and aprotinin. Enzyme 1983;30:209-12.
24. Hesse B, Lankisch PG, Kunze H. Effects of a serine protease inhibitor gabexate mesilate on purified pancreatic phospholipase A2. Pharmacol Res Commun 1984;16:637-45.
25. Okegawa T, Fujita T, Yamamoto Y, et al. Effects of FOY on experimental acute pancreatitis. Gendai Iryo (Curr Med) 1974;6:1-15.
26. Takasugi S, Yonezawa H, Kanno T. Prevention of acute experimental pancreatitis in rats and dogs by intraduodenal infusion of a synthetic trypsin inhibitor. Digestion 1982; 24:36-41.
27. Lankisch PG, Pohl U, Otto H, Goke B. Therapeutic effects of camostate (FOY 305) in acute experimental pancreatitis. Dig Dis Sci 1985;30:979.
28. Tsukiyama Y. A study of FOY in the treatment of pancreatitis. Japan J Clin Exp Med 1973;50:3681-4.
29. Fujii S. Synthetic protease inhibitor. Metabol Dis (Japan) 1977;14:1087-92.
30. Tanaka N, Tsuchiya R, Ishii K. Comparative clinical study of FOY and Trasylol in acute pancreatitis. Adv Exp Med Biol 1979;120B:367-78.
31. Freise J, Schmidt FW, Magerstedt P, Schmid K. Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis. Clin Biochem 1985;18:224-9.
32. Lampel M, Kern HF. Acute interstitial pancreatitis in the rat induced by excessive doses of pancreatic secretagogue. VirchowsArch [A] 1977;373:97-117.
33. Adler G, Rohr G, Kern HF. Alteration of membrane fusion as a cause of acute pancreatitis in the rat. Dig Dis Sci 1982;27:983-1002.
34. Renner IG, Wisner JR, Jr, Rinderknecht H. Protective effects of exogenous secretin on ceruletide induced acute pancreatitis in rats. J Clin Invest 1983;72:1081-92.
35. Watanabe O, Baccino FM, Steer ML, Meldolesi J. Effects of supramaximal caerulein stimulation on the ultrastructure of the rat pancreatic acinar cell: early morphological changes during development of experimental pancreatitis. Am J Physiol 1984;246:G457-67.
36. Adler G, Hupp T, Kern HF. Course and spontaneous regression of acute pancreatitis in the rat. Virchows Arch [A] 1979;383:32-47.
37. Niederau C, Ferrell LD, Grendell JH. Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin. Gastroenterology 1985;88:1192-204.
38. Renner IG, Wisner JR, Jr, Lavigne BC. Partial restoration of pancreatic function by exogenous secretin in rats with ceru-letide-induced acute pancreatitis. Dig Dis Sci 1986;31:30513.
39. Renner IG, Wisner JR, Jr. Ceruletide-induced acute pancreatitis in the dog and its amelioration by exogenous secretin. Int J Pancreatology 1986;1:39-49.
40. Rinderknecht H, Adham NF, Renner IG, Abramson SB. Diagnosis of pancreatic disease by fluorometric determination of plasma trypsinogen. In: Progress in clinical enzymology. New York: Masson Publishing USA, 1982(11):77-83.
41. Adler HL, Roessler EB. Introduction to probability and statistics. San Francisco: WH Freeman and Co., 1968:136-48.
42. Adler HL, Roessler EB. Introduction to probability and statistics. San Francisco: WH Freeman and Co., 1968:156-64.
43. Goke B, Stockmann F. Muller R, Lankisch PG, Creutzfeldt W. Effect of a specific serine protease inhibitor on the rat pancreas: systemic administration of camostate and exocrine pancreatic secretion. Digestion 1984;30:171-8.
44. Adler G, Rausch U, Weidenbach F, Arnold R, Kern HF. General and selective inhibition of pancreatic enzyme discharge using a proteinase inhibitor (FOY-305). Klin Wo-chenschr 1984;62:406-11.
45. Lankisch PG, Goke B, Stockman F, Otto J, Creutzfeldt W. Effect of gabexate mesilate on pancreatic secretion and on acute pancreatitis in rats. Dig Dis Sci 1983;28:937.